Erythromycin Oral Suspension Suppliers & Bulk Manufacturers
Available Forms: Oral Suspension
Available Strengths: 250 mg/5 mL, 500 mg/5 mL
Reference Brands: Erythrocin, Erythrocin V, Erythrocin Stearate(US)
Category:
Antibiotics
Erythromycin suspension inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation. It effectively treats respiratory, skin, and soft tissue infections. Benefits include rapid, broad-spectrum antibacterial activity, good tissue penetration, and ease of administration, making it ideal for pediatric and outpatient infections.
Erythromycin Oral Suspension is available in Oral Suspension
and strengths such as 250 mg/5 mL, 500 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Erythromycin Oral Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Erythromycin Oral Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Erythromycin suspension is approved in the EU and US for pediatric and adult bacterial infections, especially respiratory and skin infections. In the EU, brands like Erythrocin and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with many generics available. Both regions require detailed dossiers, including clinical trial results, quality control measures, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for erythromycin suspension, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing